245 related articles for article (PubMed ID: 33988479)
21. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
[TBL] [Abstract][Full Text] [Related]
22. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
23. A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.
Zhou WB; Chen N; Li CJ
BMC Endocr Disord; 2019 Jan; 19(1):14. PubMed ID: 30674304
[TBL] [Abstract][Full Text] [Related]
24. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
[TBL] [Abstract][Full Text] [Related]
25. Hyperandrogenism after menopause.
Markopoulos MC; Kassi E; Alexandraki KI; Mastorakos G; Kaltsas G
Eur J Endocrinol; 2015 Feb; 172(2):R79-91. PubMed ID: 25225480
[TBL] [Abstract][Full Text] [Related]
26. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
27. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
[TBL] [Abstract][Full Text] [Related]
28. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Bidzińska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
29. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.
Kaltsas GA; Isidori AM; Kola BP; Skelly RH; Chew SL; Jenkins PJ; Monson JP; Grossman AB; Besser GM
J Clin Endocrinol Metab; 2003 Jun; 88(6):2634-43. PubMed ID: 12788867
[TBL] [Abstract][Full Text] [Related]
30. Dexamethasone suppression test versus selective ovarian and adrenal vein catheterization in identifying virilizing tumors in postmenopausal hyperandrogenism - a systematic review and meta-analysis.
Tng EL; Tan JM
Gynecol Endocrinol; 2021 Jul; 37(7):600-608. PubMed ID: 33660585
[TBL] [Abstract][Full Text] [Related]
31. Effects of sex steroids on women's health: implications for practitioners.
Derman RJ
Am J Med; 1995 Jan; 98(1A):137S-143S. PubMed ID: 7825634
[TBL] [Abstract][Full Text] [Related]
32. Ovarian steroid cell tumour inducing virilisation in a postmenopausal woman.
Pinto AM; Martins MB; Oliveira N; Oliveira M
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35444026
[TBL] [Abstract][Full Text] [Related]
33. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
34. Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women.
Elhassan YS; Idkowiak J; Smith K; Asia M; Gleeson H; Webster R; Arlt W; O'Reilly MW
J Clin Endocrinol Metab; 2018 Mar; 103(3):1214-1223. PubMed ID: 29342266
[TBL] [Abstract][Full Text] [Related]
35. Management of postmenopausal virilization.
Alpañés M; González-Casbas JM; Sánchez J; Pián H; Escobar-Morreale HF
J Clin Endocrinol Metab; 2012 Aug; 97(8):2584-8. PubMed ID: 22669303
[TBL] [Abstract][Full Text] [Related]
36. Hirsutism in Women.
Matheson E; Bain J
Am Fam Physician; 2019 Aug; 100(3):168-175. PubMed ID: 31361105
[TBL] [Abstract][Full Text] [Related]
37. Postmenopausal hyperandrogenism: the under-recognized value of inhibins.
Shearer JL; Salmons N; Murphy DJ; Gama R
Ann Clin Biochem; 2017 Jan; 54(1):174-177. PubMed ID: 27278937
[TBL] [Abstract][Full Text] [Related]
38. A rare case of postmenopausal hyperandrogenism due to ovarian hyperthecosis and hilus cell hyperplasia.
Johnson JE; Hussain M; Rathore A; Wolfe K
Post Reprod Health; 2022 Mar; 28(1):51-55. PubMed ID: 35144514
[TBL] [Abstract][Full Text] [Related]
39. The adrenal cortex and virilization.
McKenna TJ; Cunningham SK; Loughlin T
Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
[TBL] [Abstract][Full Text] [Related]
40. [Hyperandrogenism in women].
Peigné M; Villers-Capelle A; Robin G; Dewailly D
Presse Med; 2013 Nov; 42(11):1487-99. PubMed ID: 24184282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
